Inovio Biomedical Corp (NASDAQ:INO)

CAPS Rating: 2 out of 5

A biomedical company which deals in developing human applications of electroporation, which uses brief, controlled electrical pulses to increase cellular uptake of a useful biopharmaceuticals.

Recs

0
Player Avatar pchop123 (80.25) Submitted: 1/14/2013 2:27:25 PM : Outperform Start Price: $2.55 INO Score: +11.32

may finally be a game changing stock & it is about time this happened

Featured Broker Partners


Advertisement